Tag: Cancer: Leukemia
Adherence to Quality Indicators Low in Chronic Myeloid Leukemia
Compliance with diagnostic and therapeutic indicators was 83 and 78 percent, while compliance with monitoring indicators was lower
Polypharmacy Prevalent Among Older Adults With Blood Cancers
Taking eight or more medications strongly associated with frailty; odds of being prefrail, frail increased with each additional med
Higher Tisagenlecleucel Doses May Improve Outcomes in Youth With B-ALL
Overall, event-free, relapse-free survival improved in patients receiving higher doses of tisagenlecleucel, with no increased toxicity
Air Pollution May Increase Risk for Childhood Leukemia
Strongest association seen for benzene exposure and acute myeloid leukemia
Dual Effect Identified for Arsenic in Carcinogenesis
Arsenic level in drinking water negatively associated with incidences of lymphoma, leukemia in men and women
Long-Term Mortality Rates Elevated for Adolescent, Young Adult Leukemia Survivors
Survival for adolescent and young adult leukemia survivors remained below general population at up to 30 years of follow-up
AACR: Novel COVID-19 Vaccine Aimed at Immunocompromised Patients
CoVac-1, a peptide vaccine, induces T-cell immune responses in those with B-cell deficiencies, particularly leukemia and lymphoma patients
Ivosidenib + Azacitidine Ups Event-Free Survival in IDH1-Mutated AML
Event-free survival significantly longer compared with placebo and azacitidine for newly diagnosed IDH1-mutated AML
AACR: Resistance Mechanisms to CAR-T Cell Therapy ID’d in ALL
Mechanisms of resistance detectable prior to treatment and include hypermethylation of PCR2 targets in embryonic and cancer stem cells
Durable Remission Seen in Two CLL Patients After CAR T Cell Therapy
CAR T cells detectable more than 10 years after infusion with sustained remission in both patients